| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 0 | 1.361 | 146 | 0 | 0 |
| Total Income - EUR | - | 0 | 0 | 0 | 0 | 18 | 2.047 | 302 | 0 | 0 |
| Total Expenses - EUR | - | 590 | 242 | 11 | 148 | 2.013 | 5.029 | 1.877 | 0 | 0 |
| Gross Profit/Loss - EUR | - | -590 | -242 | -11 | -148 | -1.995 | -2.982 | -1.575 | 0 | 0 |
| Net Profit/Loss - EUR | - | -590 | -242 | -11 | -148 | -1.995 | -3.043 | -1.584 | 0 | 0 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dermacode Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 135 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 43 | 42 | 181 | 177 | 1.868 | 1.450 | 384 | 383 | 381 |
| Inventories | - | 0 | 0 | 140 | 137 | 750 | 760 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 304 | 379 | 378 | 376 |
| Cash | - | 43 | 42 | 41 | 40 | 1.118 | 386 | 5 | 5 | 5 |
| Shareholders Funds | - | -546 | -778 | -774 | -907 | -2.885 | -6.224 | -7.827 | -7.803 | -7.760 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 723 | 820 | 955 | 1.084 | 4.753 | 7.673 | 8.217 | 8.192 | 8.146 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Dermacode Srl